CURI (CuriosityStream Inc. Class A Common Stock)

Insider Trading Activity

Every open-market purchase and sale reported by CURI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
34
most recent
Open-Market Buys
3
code P
Sales
14
code S
Reporting Insiders
10
current holders
CURI — Recent Form 4 Transactions (latest 2026-07-30)
FiledInsiderRole TypeSharesValue
2026-07-30 Theresa Ellen Cudahy COO and Secretary MIXED
2026-07-28 Phillip Brady Hayden Chief Financial Officer MIXED
2026-07-28 Rebecca R Reed Gen Counsel MIXED
2026-06-16 Patrick J. Keeley Director Sell
2026-06-16 Phillip Brady Hayden Chief Financial Officer Sell
2026-06-01 Clinton Larry Stinchcomb President and CEO Buy
2026-05-29 Clinton Larry Stinchcomb President and CEO Buy
2026-05-28 Clinton Larry Stinchcomb President and CEO Buy
2026-03-13 Clinton Larry Stinchcomb President and CEO MIXED
2026-02-12 Phillip Brady Hayden Chief Financial Officer A
2026-02-12 Rebecca R Reed Gen Counsel A
2026-02-12 John Thomas Jr Vilade Chief Commercial Officer A
2026-02-06 Michael Nikzad Director M
2026-02-06 JOHN S HENDRICKS Director A
2026-02-06 Patrick J. Keeley Director M
2026-02-06 JONATHAN HUBERMAN Director M
2026-02-06 Matthew Blank Director M
2026-02-06 Elizabeth Ann Hendricks Director M
2026-02-06 Andrew Hendricks Director M
2026-01-02 Phillip Brady Hayden Chief Financial Officer Sell
2025-12-15 Phillip Brady Hayden Chief Financial Officer Sell
2025-12-12 Theresa Ellen Cudahy COO and Secretary Sell
2025-11-25 Clinton Larry Stinchcomb President and CEO Sell
2025-11-24 Theresa Ellen Cudahy COO and Secretary Sell
2025-11-24 JONATHAN HUBERMAN Director Sell
2025-11-24 Clinton Larry Stinchcomb President and CEO Sell
2025-11-17 Phillip Brady Hayden Chief Financial Officer Sell
2025-11-17 Theresa Ellen Cudahy COO and Secretary Sell
2025-11-17 JONATHAN HUBERMAN Director Sell
2025-11-13 Rebecca R Reed Gen Counsel MIXED
2025-11-13 Clinton Larry Stinchcomb President and CEO MIXED
2025-11-13 Phillip Brady Hayden Chief Financial Officer MIXED
2025-11-10 Rebecca R Reed Gen Counsel Sell
2025-11-10 Phillip Brady Hayden Chief Financial Officer Sell
CURI — Current Insider Holders
InsiderRole Shares HeldValue
President and CEO 2,971,260
Director 1,398,619
COO and Secretary 643,749
Director 196,000
Director 188,450
Director 172,785
Director 168,221
Director 163,383
Gen Counsel 68,533
Chief Financial Officer 25,000
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the CURI quote page; the site-wide leaderboard is on the insider transactions hub.